Shukra Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE551C01044
  • NSEID:
  • BSEID: 524632
INR
31.89
0.04 (0.13%)
BSENSE

Apr 02

BSE+NSE Vol: 2.55 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.89",
    "chg": 0.04,
    "chgp": "0.13%",
    "dir": 1,
    "prev_price": "31.85",
    "mcapval": "1,374.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE551C01044",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "2.55 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 583,
    "sid": "505931",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "20-Mar-2026",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Independent Directors Meeting",
      "datetime": "16-Mar-2026",
      "details": "Independent Directors Meeting",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Independent Directors Meeting",
      "datetime": "06-Mar-2026",
      "details": "Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2026 inter alia to consider and approve Independent Directors Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Closure of Trading Window

20-Mar-2026 | Source : BSE

Closure of Trading Window

Board Meeting Outcome for Independent Directors Meeting

16-Mar-2026 | Source : BSE

Independent Directors Meeting

Board Meeting Intimation for Independent Directors Meeting

06-Mar-2026 | Source : BSE

Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2026 inter alia to consider and approve Independent Directors Meeting

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Shukra Pharmaceuticals Ltd has declared 1% dividend, ex-date: 18 Sep 25

stock-summary
SPLITS

Shukra Pharmaceuticals Ltd has announced 1:10 stock split, ex-date: 21 Mar 25

stock-summary
BONUS

Shukra Pharmaceuticals Ltd has announced 3:1 bonus issue, ex-date: 19 Apr 24

stock-summary
RIGHTS

Shukra Pharmaceuticals Ltd has announced 6:1 rights issue, ex-date: 02 Feb 23